Industry / Russia

Merck Serono's Oral MS Drug Receives First Approval

July 2010 | Industry Trend Analysis

Printable version
Bookmark

The Russian Federal Service on Surveillance in Healthcare and Social Development has approved

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

AstraZeneca Targets 28% Growth For 2010

Industry / Russia Anglo-Swedish pharmaceutical company AstraZeneca intends to build upon positive revenue performance in Russia during 2009. The drugmaker will attempt to drive sales growth rates by expanding its innovative...

March 2010

Price Monitoring Reveals Strong Inflation And Breaches Of Limits

Industry / Russia Pharmaceutical prices in Russia and Ukraine have been under intense scrutiny since the latter part of 2008, as a result of negative economic conditions, associated currency devaluations and profiteering...

March 2010

Small Steps Towards GMP Compliance

Industry / Russia Aligning Russian pharmaceutical manufacturing with international standards is an essential measure if the country is to build a domestic industry capable of competing with more developed multinational...

March 2010

Pharmaceutical Production Down In 2009

Industry / Russia Russia's pharmaceutical manufacturing industry was hit hard during 2009, with production amounting to only 91.7% of 2008 levels, according to data released by the Ministry of Industry and Trade of the...

February 2010

Local Trials To Become A Pre-Requisite For Foreign Drugs

Industry / Russia Clinical testing of pharmaceuticals in Russia would become mandatory for foreign companies if a new bill under consideration in Russia's lower house of parliament, the State Duma, is approved. New requirements...

January 2010